What’s the deal with oral GLP-1s?

February 24, 2026
5 minutes
Author:

Bodies come in all shapes and sizes, but this doesn’t mean that those seeking weight-loss medication want a one-size-fits-all approach. Whether you’re wanting to lose weight to feel better, look better, move better, or a bit of all three, it’s important to reach a healthy weight and habits that best suit your lifestyle.

As interest in weight-loss medications continues to grow, so does interest in other options, specifically with oral alternatives. In this article, we’ll break down what’s currently available for oral GLP-1s and some of the challenges surrounding this type of weight-loss medication. 

What is the difference between injectable and oral GLP-1s?

The most common GLP-1 medications, like Wegovy® and Ozempic®, come in injectable form, requiring weekly injections. Oral GLP-1s, on the other hand, come in liquid or tablet form and are taken daily. With the exception of Rybelsus® (more on that below), these are compounded by pharmacies, usually using a semaglutide base.

Why brand-name oral GLP-1 options are limited

Currently, only one FDA-approved oral GLP-1 choice exists: Rybelsus® by Novo Nordisk. However, it has only been approved for type 2 diabetes, not weight loss, and comes in 3 mg, 7 mg, and 14 mg doses, with its max dose still lower than the Wegovy® injectable version.

While there are efforts being made to get a higher dose approved by the FDA, there are strict absorption requirements, as medication must be taken on an empty stomach with limited water and no food for 30 minutes.

Pharmaceutical barriers

No oral GLP-1 formulation for weight loss has received FDA approval, as oral delivery of GLP-1 is scientifically challenging due to peptide breakdown in the stomach. (Rybelsus® uses a special absorption enhancer (SNAC) to work, which is proprietary.) 

In addition, production costs are high, and meeting strict FDA requirements is a lengthy process.

Compounded oral GLP-1s are on the rise

Despite these barriers, demand for these medications has risen, and healthcare providers are prescribing compounded oral semaglutide versions for patients they feel would benefit from an oral version. While the FDA has deemed that the GLP-1 medication shortage is over—for now—many patients and providers still prefer compounded oral GLP-1s* due to convenience and lack of needles. Oral GLP-1 alternatives are also available via telehealth and online clinics, making access easier.

Liquid drops or lozenges?

The most popular oral GLP-1 options—liquid drops and lozenges (tablets)—may be slightly less potent than injectable GLP-1s, which means side effects may be fewer, making them a more attractive option for some patients. 

Liquid drops:

  • Taken once a day
  • Absorbed under the tongue to bypass digestion and enter the bloodstream quickly
  • Side effects may include mild nausea or dry mouth, but in general, they are very well tolerated

Lozenges 

  • Taken once or twice a day, depending on response and goals
  • Dissolve slowly under the tongue, allowing semaglutide to be absorbed through the oral mucosa

Liquid drops and lozenges may be a good oral GLP-1 alternative prescribed by licensed providers for those looking to avoid needles, those transitioning down from injectables, or those just starting their weight-loss journey. Visit tryshed.com to learn more.

What’s next for oral GLP-1s?

Novo Nordisk® is reportedly testing higher-dose oral semaglutide for obesity treatment with ongoing clinical trials. If approved, it would be the first FDA-approved oral GLP-1 for weight loss.

Several companies, including Lilly®, are investing in oral GLP-1 candidates with improved bioavailability and fewer dietary restrictions. Oral tirzepatide is in early-stage trials.

Until an FDA-approved GLP-1 for weight loss is approved, compounded oral alternatives may be available if prescribed by a licensed healthcare professional through. Check with your provider to see what options are available to you.

In conclusion

The weight-loss market is ever changing, so work closely with a licensed provider before starting any new medication, and be cautious of non-accredited online sellers. Shed only works with licensed providers to provide quality, consistent care for Shed members.

Compounded medications are prepared by licensed pharmacies to meet individual patient needs. While they are not reviewed or approved by the FDA for safety or effectiveness, they are made in accordance with strict regulatory guidelines. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate.

No insurance required
FDA approved options
Clinically studied
100% online visit + checkout

<script type="application/ld+json">
{
 "@context": "https://schema.org",
 "@type": "Article",
 "headline": "What’s the deal with oral GLP-1s?",
 "description": "An overview of oral GLP-1 options, differences from injectables, pharmaceutical and regulatory barriers, compounded alternatives, formulation types (drops, tablets, lozenges), and guidance on safety and provider oversight.",
 "author": {
   "@type": "Person",
   "name": "ShedRX Editorial Team"
 },
 "publisher": {
   "@type": "Organization",
   "name": "ShedRX"
 },
 "datePublished": "2024-01-01",
 "dateModified": "2026-02-24",
 "image": [],
 "wordCount": 1430,
 "articleSection": "GLP-1s",
 "keywords": [
   "oral GLP-1",
   "semaglutide",
   "Rybelsus",
   "compounded medications",
   "sublingual",
   "liquid drops",
   "lozenges",
   "liposomal tablets",
   "bioavailability",
   "weight loss"
 ]
}
</script>

<script type="application/ld+json">
{
 "@context": "https://schema.org",
 "@type": "FAQPage",
 "mainEntity": [
   {
     "@type": "Question",
     "name": "How do oral GLP-1 liquid drops, liposomal tablets, and lozenges compare to injectables for weight loss?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Oral options can be effective for some patients, but injectables remain the most studied and typically provide the strongest effect size in trials. Oral products usually require daily dosing and careful administration to aid absorption. Side effects with oral drops, tablets, or lozenges may be milder. Always discuss goals and medical history with a licensed Shed provider before switching."
     }
   },
   {
     "@type": "Question",
     "name": "Why is Rybelsus approved for diabetes but not for weight loss?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Rybelsus earned approval based on diabetes trials and labeling; weight-loss indications require separate clinical trials and FDA review of obesity outcomes and dosing. Higher-dose oral semaglutide for obesity is under study. A Shed provider can help weigh current options and dosing differences."
     }
   },
   {
     "@type": "Question",
     "name": "How do sublingual drops bypass digestion?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "When held under the tongue, part of the dose can pass through the oral mucosa into the bloodstream, bypassing stomach acid and digestive enzymes that break down peptides. Bioavailability depends on formulation and technique; follow your Shed dosing instructions and avoid eating or drinking while the dose is absorbing."
     }
   },
   {
     "@type": "Question",
     "name": "What should I discuss with a provider before choosing compounded oral semaglutide?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Review medical history, current medications, pregnancy or breastfeeding status, past GI issues, risk for pancreatitis or gallbladder problems, and preference for daily oral versus weekly injections. Ask about dose titration, monitoring plans, and pharmacy quality. Shed connects patients with licensed providers and vetted pharmacy partners for ongoing support."
     }
   },
   {
     "@type": "Question",
     "name": "Are there specific risks with compounded GLP-1 products?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Compounded drugs are not FDA-approved and may have variability in potency or quality if not sourced and prepared correctly. Choose licensed providers, verify pharmacy accreditation when possible, and ask about API sourcing and batch testing. Shed emphasizes safety, counseling, and follow-up."
     }
   },
   {
     "@type": "Question",
     "name": "When might a clinician recommend transitioning from weekly injections to daily oral drops or lozenges?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Reasons include needle aversion, supply or access challenges, mild side effects on injectables, or a desire to taper dose intensity while maintaining lifestyle changes. Your Shed provider can help design a safe transition with appropriate monitoring."
     }
   },
   {
     "@type": "Question",
     "name": "How are pharmaceutical companies improving oral GLP-1 bioavailability?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Approaches include absorption enhancers like SNAC, enteric coatings, mucoadhesive and nanoparticle systems, liposomal technology, and peptide modifications to resist digestion. Several oral semaglutide or tirzepatide candidates are in trials."
     }
   },
   {
     "@type": "Question",
     "name": "Where can I learn more about lifestyle and dosing tips for sublingual GLP-1s?",
     "acceptedAnswer": {
       "@type": "Answer",
       "text": "Read Shed’s lifestyle guide to sublingual GLP-1 medications and the overview on using GLP-1s for weight loss on tryshed.com, and review the oral liquid drops product page for additional information and dosing guidance."
     }
   }
 ]
}
</script>